CN117815335A - 一种基于脂肪干细胞svf的骨关节炎治疗组合物及其制备方法 - Google Patents
一种基于脂肪干细胞svf的骨关节炎治疗组合物及其制备方法 Download PDFInfo
- Publication number
- CN117815335A CN117815335A CN202410245249.2A CN202410245249A CN117815335A CN 117815335 A CN117815335 A CN 117815335A CN 202410245249 A CN202410245249 A CN 202410245249A CN 117815335 A CN117815335 A CN 117815335A
- Authority
- CN
- China
- Prior art keywords
- svf
- adipose
- stem cell
- treatment composition
- composition based
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000000130 stem cell Anatomy 0.000 title claims abstract description 56
- 201000008482 osteoarthritis Diseases 0.000 title claims abstract description 30
- 239000000203 mixture Substances 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 239000003814 drug Substances 0.000 claims abstract description 29
- 239000007924 injection Substances 0.000 claims abstract description 5
- 238000002347 injection Methods 0.000 claims abstract description 5
- 238000004821 distillation Methods 0.000 claims description 25
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 15
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 11
- 241000218202 Coptis Species 0.000 claims description 10
- 235000002991 Coptis groenlandica Nutrition 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 9
- 238000012360 testing method Methods 0.000 claims description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 7
- 210000004027 cell Anatomy 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 6
- 238000009835 boiling Methods 0.000 claims description 6
- 239000003480 eluent Substances 0.000 claims description 6
- 239000002674 ointment Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 210000000577 adipose tissue Anatomy 0.000 claims description 5
- 239000002504 physiological saline solution Substances 0.000 claims description 5
- 241000037740 Coptis chinensis Species 0.000 claims description 4
- 241000382455 Angelica sinensis Species 0.000 claims description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 3
- 102000029816 Collagenase Human genes 0.000 claims description 3
- 108060005980 Collagenase Proteins 0.000 claims description 3
- 241001571764 Lysimachia christinae Species 0.000 claims description 3
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 3
- 239000001569 carbon dioxide Substances 0.000 claims description 3
- 238000004113 cell culture Methods 0.000 claims description 3
- 239000006285 cell suspension Substances 0.000 claims description 3
- 229960002424 collagenase Drugs 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 238000012258 culturing Methods 0.000 claims description 3
- 238000007865 diluting Methods 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 239000001963 growth medium Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 230000001105 regulatory effect Effects 0.000 claims description 3
- 239000011347 resin Substances 0.000 claims description 3
- 229920005989 resin Polymers 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 239000008215 water for injection Substances 0.000 claims description 3
- 240000004638 Dendrobium nobile Species 0.000 claims description 2
- 238000005119 centrifugation Methods 0.000 claims description 2
- 244000061520 Angelica archangelica Species 0.000 claims 1
- 210000000845 cartilage Anatomy 0.000 abstract description 13
- 230000002757 inflammatory effect Effects 0.000 abstract description 10
- 238000011084 recovery Methods 0.000 abstract description 8
- 210000001188 articular cartilage Anatomy 0.000 abstract description 4
- 210000000988 bone and bone Anatomy 0.000 abstract description 4
- 206010061218 Inflammation Diseases 0.000 abstract description 2
- 230000004054 inflammatory process Effects 0.000 abstract description 2
- 238000002660 stem cell treatment Methods 0.000 abstract description 2
- 230000000052 comparative effect Effects 0.000 description 14
- 241001523681 Dendrobium Species 0.000 description 11
- 241000522190 Desmodium Species 0.000 description 11
- 241000125175 Angelica Species 0.000 description 10
- 230000000694 effects Effects 0.000 description 6
- 239000012535 impurity Substances 0.000 description 4
- 238000011476 stem cell transplantation Methods 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000028709 inflammatory response Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 108010049955 Bone Morphogenetic Protein 4 Proteins 0.000 description 1
- 102100024505 Bone morphogenetic protein 4 Human genes 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 102000003777 Interleukin-1 beta Human genes 0.000 description 1
- 108090000193 Interleukin-1 beta Proteins 0.000 description 1
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000002424 anti-apoptotic effect Effects 0.000 description 1
- 230000003510 anti-fibrotic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001612 chondrocyte Anatomy 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000002637 fluid replacement therapy Methods 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000002894 multi-fate stem cell Anatomy 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229940126672 traditional medicines Drugs 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410245249.2A CN117815335B (zh) | 2024-03-05 | 2024-03-05 | 一种基于脂肪干细胞svf的骨关节炎治疗组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410245249.2A CN117815335B (zh) | 2024-03-05 | 2024-03-05 | 一种基于脂肪干细胞svf的骨关节炎治疗组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN117815335A true CN117815335A (zh) | 2024-04-05 |
CN117815335B CN117815335B (zh) | 2024-07-09 |
Family
ID=90504394
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202410245249.2A Active CN117815335B (zh) | 2024-03-05 | 2024-03-05 | 一种基于脂肪干细胞svf的骨关节炎治疗组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117815335B (zh) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101301406A (zh) * | 2008-07-01 | 2008-11-12 | 黄显能 | 治疗骨质增生、椎间盘突出以及颈椎炎、风湿关节炎的外敷剂 |
CN105106238A (zh) * | 2015-08-10 | 2015-12-02 | 山东省药学科学院 | 一种用于治疗骨关节炎和软骨缺损的细胞治疗组合物 |
CN108653329A (zh) * | 2018-05-28 | 2018-10-16 | 广东唯泰生物科技有限公司 | 一种用于治疗骨关节炎的药物及其制备方法 |
CN110856752A (zh) * | 2018-08-23 | 2020-03-03 | 青岛西凯生物技术有限公司 | 一种自体脂肪干细胞+prp治疗骨性关节炎的实验方法 |
CN110974848A (zh) * | 2019-12-30 | 2020-04-10 | 烟台知兴知识产权咨询服务有限公司 | 一种人源脂肪干细胞对骨关节炎治疗的培育药物及使用方法 |
CN111607560A (zh) * | 2019-02-22 | 2020-09-01 | 深圳安吉赛尔生物科技有限公司 | 一种脂肪干细胞的培养方法及其在关节炎中的应用 |
CN115381856A (zh) * | 2022-08-30 | 2022-11-25 | 博品(上海)生物医药科技有限公司 | 脂肪间充质干细胞在制备治疗膝骨关节炎药物或制剂中的用途 |
-
2024
- 2024-03-05 CN CN202410245249.2A patent/CN117815335B/zh active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101301406A (zh) * | 2008-07-01 | 2008-11-12 | 黄显能 | 治疗骨质增生、椎间盘突出以及颈椎炎、风湿关节炎的外敷剂 |
CN105106238A (zh) * | 2015-08-10 | 2015-12-02 | 山东省药学科学院 | 一种用于治疗骨关节炎和软骨缺损的细胞治疗组合物 |
CN108653329A (zh) * | 2018-05-28 | 2018-10-16 | 广东唯泰生物科技有限公司 | 一种用于治疗骨关节炎的药物及其制备方法 |
CN110856752A (zh) * | 2018-08-23 | 2020-03-03 | 青岛西凯生物技术有限公司 | 一种自体脂肪干细胞+prp治疗骨性关节炎的实验方法 |
CN111607560A (zh) * | 2019-02-22 | 2020-09-01 | 深圳安吉赛尔生物科技有限公司 | 一种脂肪干细胞的培养方法及其在关节炎中的应用 |
CN110974848A (zh) * | 2019-12-30 | 2020-04-10 | 烟台知兴知识产权咨询服务有限公司 | 一种人源脂肪干细胞对骨关节炎治疗的培育药物及使用方法 |
CN115381856A (zh) * | 2022-08-30 | 2022-11-25 | 博品(上海)生物医药科技有限公司 | 脂肪间充质干细胞在制备治疗膝骨关节炎药物或制剂中的用途 |
Also Published As
Publication number | Publication date |
---|---|
CN117815335B (zh) | 2024-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100446779C (zh) | 一种制备刺五加提取液/物的方法 | |
CN108624495B (zh) | 一种制备降高尿酸的葵花盘功能活性肽的方法 | |
CN112451655B (zh) | 一种抗疲劳组合物及其应用 | |
CN101249259B (zh) | 一种高含量、高活性口服云芝糖肽及其制备方法和应用 | |
CN112870236A (zh) | 一种黄蜀葵花黄酮类有效部位及其制备方法与应用 | |
CN102872015B (zh) | 一种白药子总生物碱提取物及其制备方法及应用 | |
CN104284601A (zh) | 用于促进类胰岛素生长因子分泌及骨骼生长的白何首乌提取物和续断提取物及其制造方法 | |
CN114702536A (zh) | 一种新型环烯醚萜苷二聚体的制备方法及其应用 | |
CN117815335B (zh) | 一种基于脂肪干细胞svf的骨关节炎治疗组合物及其制备方法 | |
CN110755598A (zh) | 活化胰岛素及治疗糖尿病的复合苦瓜肽口服药及制备方法 | |
CN105943569A (zh) | 一种青梅有效成分的提取方法 | |
CN1814170A (zh) | 一种治疗心血管疾病的药物滴丸及其制备方法 | |
CN107137438A (zh) | 蜡梅属植物抗结核杆菌的用途 | |
KR101407611B1 (ko) | 산약을 포함하는 안면신경마비 치료용 약제의 제조방법과 그 추출물 | |
CN117959350B (zh) | 一种基于复合干细胞svf的骨关节炎治疗组合物 | |
CN110559327B (zh) | 一种护肝产品及其制备方法 | |
CN105796625A (zh) | 含红曲红花的药物组合物及其制剂 | |
CN107875215B (zh) | 一种用于贫血的中药组合物 | |
CN107929351B (zh) | 一种艾迪注射制剂的制备工艺 | |
CN116870094B (zh) | 一种清热解毒口服液的制备方法 | |
CN109985095A (zh) | 一种制备兽用双黄连口服液澄清制剂的方法 | |
CN109172643A (zh) | 一种双黄连注射液及其制备工艺 | |
CN100479804C (zh) | 藏药独一味注射制剂及其制备方法 | |
CN109485711B (zh) | 一种蚁狮小分子肽及其分离纯化方法和应用 | |
CN116731213B (zh) | 一种何首乌多糖及其提取方法和在制备保肝药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20240612 Address after: Floor 3, Building 3, Pansheng Biological Industrial Park, Gangyuan 8th Road, Jinan Area, China (Shandong) Pilot Free Trade Zone, 250000, Jinan, Shandong Applicant after: Saier Medical Technology (Shandong) Co.,Ltd. Country or region after: China Address before: Room 23, 5th Floor, Building S3, Shuangqi Longcheng International Community, No. 778 New Hunan Street, Xinhu Street Office, Decheng District, Dezhou City, Shandong Province, 253000 Applicant before: Shandong Keruinuo Biotechnology Co.,Ltd. Country or region before: China |
|
GR01 | Patent grant |